Neurocrine Biosciences
NBIX
#1482
Rank
ยฃ9.10 B
Marketcap
ยฃ90.18
Share price
-1.75%
Change (1 day)
-3.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ2.51 B

According to Neurocrine Biosciences 's latest financial reports the company's total assets are ยฃ2.51 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ2.55 B30.35%
2022-12-31ยฃ1.95 B27.86%
2021-12-31ยฃ1.53 B20.51%
2020-12-31ยฃ1.27 B29.12%
2019-12-31ยฃ0.98 B26.44%
2018-12-31ยฃ0.77 B28.67%
2017-12-31ยฃ0.60 B104.46%
2016-12-31ยฃ0.29 B-7.55%
2015-12-31ยฃ0.32 B105.01%
2014-12-31ยฃ0.15 B66.69%
2013-12-31ยฃ93.65 M-22.72%
2012-12-31ยฃ0.12 B36.14%
2011-12-31ยฃ89.02 M-5.17%
2010-12-31ยฃ93.87 M112.78%
2009-12-31ยฃ44.11 M-46.17%
2008-12-31ยฃ81.96 M-40.85%
2007-12-31ยฃ0.13 B-30.35%
2006-12-31ยฃ0.19 B-28.99%
2005-12-31ยฃ0.28 B3.5%
2004-12-31ยฃ0.27 B-13.5%
2003-12-31ยฃ0.31 B88.24%
2002-12-31ยฃ0.16 B-30.41%
2001-12-31ยฃ0.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ2.18 B-13.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.45 B 434.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ8.69 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ54.76 B 2,074.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ108.15 B 4,194.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ164.73 B 6,441.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.70 B-72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.65 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA